Depends on your outlook Alydyr.
NNVC has decent volume most of the time and with fairly regular up & down swings. So if one is inclined to trade, it's not a bad stock for trading purposes.
NNVC also has a fairly impressive portfolio or patents (liscenced from another insider company at reasonable terms) at it's disposal, a new manufacturing plant that is coming online sometime (likely) in early 2015, and a pipeline of antiviral drug candidates. One or two of those drug candidates are likely to hit clinical testing stages during late 2015, or potentially into early 2016.
Preclinical work with a couple of the candidate drugs on lab animals suggests that the drugs should have high efficacy, and should display very low toxicity,....
Do some digging - make your own decisions. Any specific questions - you'll get plenty of answers (pro & con) from those who post here if only you ask.
News 
Market Data 
Discover 
